Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking

Clinica Chimica Acta

Volumn 380, Issue 1-2, 2007, Pages 50-58

  Lykkesfeldt, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biomarkers; Malondialdehyde; Smoking; Thiobarbituric acid reactive substances

Indexed keywords

BIOLOGICAL MARKER; LIPID; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

BLOOD LEVEL; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLUORESCENCE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID OXIDATION; MASS SPECTROMETRY; MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SMOKING; SPECTROPHOTOMETRY;

BIOLOGICAL MARKERS; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; OXIDATIVE STRESS; SMOKING;

EID: 33947615665     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.01.028     Document Type: Review

References (90)

1. Sies H. Biochemistry of oxidative stress. Angew Chem Int Ed Engl 25 (1986) 1058-1071
2. Pryor W.A., and Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 686 (1993) 12-27
3. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd ed (1999), Oxford University Press, New York
4. Halliwell B., and Poulsen H.E. Oxidative stress. In: Halliwell B., and Poulsen H.E. (Eds). Cigarette smoke and oxidative stress (2006), Springer-Verlag, Berlin 1-5
5. Pryor W.A., and Stanley J.P. A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 40 (1975) 3615-3617
6. Frankel E.N., and Neff W.E. Formation of malonaldehyde from lipid oxidation products. Biochim Biophys Acta 754 (1983) 264-270
7. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11 (1991) 81-128
8. Hecker M., and Ullrich V. On the mechanism of prostacyclin and thromboxane A2 biosynthesis. J Biol Chem 264 (1989) 141-150
9. Valenzuela A. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci 48 (1991) 301-309
10. Nair V., Cooper C.S., Vietti D.E., and Turner G.A. The chemistry of lipid peroxidation metabolites: crosslinking reactions of malondialdehyde. Lipids 21 (1986) 6-10
11. Marnett L.J. Chemistry and biology of DNA damage by malondialdehyde. IARC Sci Publ (1999) 17-27
12. Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 424 (1999) 83-95
13. Del R.D., Stewart A.J., and Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15 (2005) 316-328
14. Draper H.H., and Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186 (1990) 421-431
15. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186 (1990) 407-421
16. Lykkesfeldt J. Determination of malondialdehyde as dithiobarbituric acid adduct in biological samples by HPLC with fluorescence detection: comparison with ultraviolet-visible spectrophotometry. Clin Chem 47 (2001) 1725-1727
17. Bull A.W., and Marnett L.J. Determination of malondialdehyde by ion-pairing high-performance liquid chromatography. Anal Biochem 149 (1985) 284-290
18. Esterbauer H., Lang J., Zadravec S., and Slater T.F. Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol 105 (1984) 319-328
19. Karatas F., Karatepe M., and Baysar A. Determination of free malondialdehyde in human serum by high-performance liquid chromatography. Anal Biochem 311 (2002) 76-79
20. Largilliere C., and Melancon S.B. Free malondialdehyde determination in human plasma by high-performance liquid chromatography. Anal Biochem 170 (1988) 123-126
21. Yeo H.C., Helbock H.J., Chyu D.W., and Ames B.N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal Biochem 220 (1994) 391-396
22. Wilson D.W., Metz H.N., Graver L.M., and Rao P.S. Direct method for quantification of free malondialdehyde with high-performance capillary electrophoresis in biological samples. Clin Chem 43 (1997) 1982-1984
23. Lykkesfeldt J., Viscovich M., and Poulsen H.E. Ascorbic acid recycling in human erythrocytes is induced by smoking in vivo. Free Radic Biol Med 35 (2003) 1439-1447
24. Lykkesfeldt J., Prieme H., Loft S., and Poulsen H.E. Effect of smoking cessation on plasma ascorbic acid concentration. BMJ 313 (1996) 91
25. Lykkesfeldt J. Smoking depletes vitamin C: should smokers be recommended to take supplements?. In: Halliwell B., and Poulsen H.E. (Eds). Cigarette smoke and oxidative stress (2006), Springer Verlag 237-260
26. Lykkesfeldt J. Vitamin C as biomarker and treatment of oxidative stress caused by smoking: methodological and clinical studies (2005), University of Copenhagen 1-59
27. Poulsen H.E., Loft S., Prieme H., et al. Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Radic Res 29 (1998) 565-571
28. Lykkesfeldt J., Christen S., Wallock L.M., Chang H.H., Jacob R.A., and Ames B.N. Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am J Clin Nutr 71 (2000) 530-536
29. Dietrich M., Block G., Norkus E.P., et al. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 77 (2003) 160-166
30. Bolisetty S., Naidoo D., Lui K., et al. Postnatal changes in maternal and neonatal plasma antioxidant vitamins and the influence of smoking. Arch Dis Child Fetal Neonatal Ed 86 (2002) F36-F40
31. Berr C., Coudray C., Bonithon-Kopp C., Roussel A.M., Mainard F., and Alperovitch A. Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA study. Int J Vitam Nutr Res 68 (1998) 26-35
32. Marangon K., Herbeth B., Lecomte E., et al. Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr 67 (1998) 231-239
33. Celec P., Hodosy J., Celecova V., et al. Salivary thiobarbituric acid reacting substances and malondialdehyde-their relationship to reported smoking and to parodontal status described by the papillary bleeding index. Dis Markers 21 (2005) 133-137
34. Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.R., and Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 43 (1997) 1209-1214
35. Block G., Dietrich M., Norkus E.P., et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 156 (2002) 274-285
36. Santos M.T., Valles J., Aznar J., Beltran M., and Herraiz M. Effect of smoking on plasma and platelet fatty acid composition in middle-aged men. Atherosclerosis 50 (1984) 53-62
37. Solak Z.A., Kabaroglu C., Cok G., et al. Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people. Clin Exp Med 5 (2005) 99-105
38. Durak I., Elgun S., Kemal B.N., et al. Effects of cigarette smoking with different tar content on erythrocyte oxidant/antioxidant status. Addict Biol 7 (2002) 255-258
39. Hodosy J., and Celec P. Daytime of sampling, tooth-brushing and ascorbic acid influence salivary thiobarbituric acid reacting substances-a potential clinical marker of gingival status. Dis Markers 21 (2005) 203-207
40. Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 23 (2002) 2129-2133
41. Measurement of DNA oxidation in human cells by chromatographic and enzymic methods. Free Radic Biol Med 34 (2003) 1089-1099
42. Collins A.R., Dusinska M., Gedik C.M., and Stetina R. Oxidative damage to DNA: do we have a reliable biomarker?. Environ Health Perspect 104 Suppl. 3 (1996) 465-469
43. Collins A.R., Gedik C.M., Olmedilla B., Southon S., and Bellizzi M. Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. FASEB J 12 (1998) 1397-1400
44. Riis B. Comparison of results from different laboratories in measuring 8-oxo-2′-deoxyguanosine in synthetic oligonucleotides. Free Radic Res 36 (2002) 649-659
45. Liu J., Yeo H.C., Doniger S.J., and Ames B.N. Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal Biochem 245 (1997) 161-166
46. Hu Y., Block G., Norkus E.P., Morrow J.D., Dietrich M., and Hudes M. Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr 84 (2006) 70-76
47. Liu C.S., Chen H.W., Lii C.K., Chen S.C., and Wei Y.H. Alterations of small-molecular-weight antioxidants in the blood of smokers. Chem Biol Interact 116 (1998) 143-154
48. Liu C.S., and Wei Y.H. Age-associated alteration of blood thiol-group-related antioxidants in smokers. Environ Res 80 (1999) 18-24
49. Duthie G.G., and Arthur J.R. Cigarette smoking as an inducer of oxidative stress. In: Sen C.K., and Packer L. (Eds). Exercise and oxygen toxicity (1994), Elsevier, Amsterdam 297-317
50. Kim S.H., Kim J.S., Shin H.S., and Keen C.L. Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 19 (2003) 240-243
51. Lykkesfeldt J., Loft S., Nielsen J.B., and Poulsen H.E. Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 65 (1997) 959-963
52. Ozguner F., Koyu A., and Cesur G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health 21 (2005) 21-26
53. Tanriverdi H., Evrengul H., Kuru O., et al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J 70 (2006) 593-599
54. Zhou J.F., Yan X.F., Guo F.Z., Sun N.Y., Qian Z.J., and Ding D.Y. Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed Environ Sci 13 (2000) 44-55
55. Duthie G.G., Arthur J.R., Beattie J.A., et al. Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann N Y Acad Sci 686 (1993) 120-129
56. Ayaori M., Hisada T., Suzukawa M., et al. Plasma levels and redox status of ascorbic acid and levels of lipid peroxidation products in active and passive smokers. Environ Health Perspect 108 (2000) 105-108
57. Rankinen T., Hietanen E., Vaisanen S., et al. Relationship between lipid peroxidation and plasma fibrinogen in middle-aged men. Thromb Res 99 (2000) 453-459
58. Fahn H.J., Wang L.S., Kao S.H., Chang S.C., Huang M.H., and Wei Y.H. Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am J Respir Cell Mol Biol 19 (1998) 901-909
59. Hanta I., Kocabas A., Canacankatan N., Kuleci S., and Seydaoglu G. Oxidant-antioxidant balance in patients with COPD. Lung 184 (2006) 51-55
60. Miller III E.R., Appel L.J., Jiang L., and Risby T.H. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 96 (1997) 1097-1101
61. Jozwik M., Jozwik M., Kuczynski W., and Szamatowicz M. Nonenzymatic antioxidant activity of human seminal plasma. Fertil Steril 68 (1997) 154-157
62. Sharma S.B., Dwivedi S., Prabhu K.M., Singh G., Kumar N., and Lal M.K. Coronary risk variables in young asymptomatic smokers. Indian J Med Res 122 (2005) 205-210
63. Nadeem A., Raj H.G., and Chhabra S.K. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 29 (2005) 23-32
64. Ozbay B., and Dulger H. Lipid peroxidation and antioxidant enzymes in Turkish population: relation to age, gender, exercise, and smoking. Tohoku J Exp Med 197 (2002) 119-124
65. Lykkesfeldt J., Viscovich M., and Poulsen H.E. Plasma malondialdehyde is induced by smoking: a study with balanced antioxidant profiles. Br J Nutr 92 (2004) 203-206
66. Jacob R.A., Aiello G.M., Stephensen C.B., et al. Moderate antioxidant supplementation has no effect on biomarkers of oxidant damage in healthy men with low fruit and vegetable intakes. J Nutr 133 (2003) 740-743
67. Kalra J., Chaudhary A.K., and Prasad K. Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 72 (1991) 1-7
68. Hirai N., Kawano H., Hirashima O., et al. Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C. Am J Physiol Heart Circ Physiol 279 (2000) H1172-H1178
69. Durak I., Yalcin S., Burak Cimen M.Y., Buyukkocak S., Kacmaz M., and Ozturk H.S. Effects of smoking on plasma and erythrocyte antioxidant defense systems. J Toxicol Environ Health A 56 (1999) 373-378
70. Volkovova K., Barancokova M., Kazimirova A., et al. Antioxidant supplementation reduces inter-individual variation in markers of oxidative damage. Free Radic Res 39 (2005) 659-666
71. Rust P., Lehner P., and Elmadfa I. Relationship between dietary intake, antioxidant status and smoking habits in female Austrian smokers. Eur J Nutr 40 (2001) 78-83
72. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 30 (2001) 178-186
73. Lim P.S., Wang N.P., Lu T.C., et al. Evidence for alterations in circulating low-molecular-weight antioxidants and increased lipid peroxidation in smokers on hemodialysis. Nephron 88 (2001) 127-133
74. Brown K.M., Morrice P.C., and Duthie G.G. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am J Clin Nutr 60 (1994) 383-387
75. Wang N.P., Lim P.S., Chen T.T., Thien L.M., Wang T.H., and Hsu W.M. Smoking is associated with alterations of blood thiol-group related antioxidants in patients on hemodialysis. Nephron 92 (2002) 772-779
76. Sanderson K.J., van Rij A.M., Wade C.R., and Sutherland W.H. Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis 118 (1995) 45-51
77. Vassalle C., Lubrano V., L'Abbate A., and Clerico A. Determination of nitrite plus nitrate and malondialdehyde in human plasma: analytical performance and the effect of smoking and exercise. Clin Chem Lab Med 40 (2002) 802-809
78. Nowak D., Kasielski M., Antczak A., Pietras T., and Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 93 (1999) 389-396
79. Leonard M.B., Lawton K., Watson I.D., and MacFarlane I. Free radical activity in young adult cigarette smokers. J Clin Pathol 48 (1995) 385-387
80. Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol 6 (2005) 13
81. Bamonti F., Novembrino C., Ippolito S., et al. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study. Clin Chem Lab Med 44 (2006) 391-395
82. Calikoglu M., Unlu A., Tamer L., Ercan B., Bugdayci R., and Atik U. The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin Chem Lab Med 40 (2002) 1028-1031
83. Ermis B., Yildirim A., Ors R., Tastekin A., Ozkan B., and Akcay F. Influence of smoking on serum and milk malondialdehyde, superoxide dismutase, glutathione peroxidase, and antioxidant potential levels in mothers at the postpartum seventh day. Biol Trace Elem Res 105 (2005) 27-36
84. Mol M.J., De Rijke Y.B., Demacker P.N., and Stalenhoef A.F. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 129 (1997) 169-176
85. Sheu J.Y., Chen P.H., Tseng W.C., Chen C.Y., Tsai L.Y., and Huang Y.L. Spectrophotometric determination of a thiobarbituric acid-reactive substance in human hair. Anal Sci 19 (2003) 957-960
86. Scheffler E., Wiest E., Woehrle J., et al. Smoking influences the atherogenic potential of low-density lipoprotein. Clin Investig 70 (1992) 263-268
87. Siekmeier R., Wulfroth P., Wieland H., Gross W., and Marz W. Low-density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers. Clin Chem 42 (1996) 524-530
88. Yamaguchi Y., Haginaka J., Morimoto S., Fujioka Y., and Kunitomo M. Facilitated nitration and oxidation of LDL in cigarette smokers. Eur J Clin Invest 35 (2005) 186-193
89. Schmid P., Karanikas G., Kritz H., et al. Passive smoking and platelet thromboxane. Thromb Res 81 (1996) 451-460
90. Laudat A., Lecourbe K., and Palluel A.M. Tobacco: a potential inductor of lipid peroxidation of the human spermatozoon membrane?. Ann Biol Clin (Paris) 62 (2004) 681-686